Latest Boardroom Shifts News

Leo Lithium has completed the sale of its remaining interest in the Goulamina Project, distributing over A$249 million to shareholders and restructuring its board as it pivots towards new asset acquisitions.

Taruga Minerals reports significant progress in Western Australia with new exploration license applications and ongoing copper project developments, alongside key corporate changes and a stable cash position.

Clara Resources outlines key progress on its Ashford Coking Coal Project drilling preparations and details ongoing capital management initiatives, including rights issues and entitlement offers, while navigating boardroom challenges.

Galena Mining Limited reports a challenging December quarter at its 60%-owned Abra Base Metals Mine, marked by production declines and ongoing voluntary administration. The company appoints a new CEO for Abra and explores recapitalisation options to stabilise operations.

Coppermoly Limited has advanced its Mt Isa exploration program with fresh geophysical surveys and strategic board appointments, aiming to unlock new copper and gold targets in Queensland.

Cycliq Group Ltd reports a robust Q2 FY2025 with a 15% rise in cash receipts to $1.92 million and strategic leadership appointments aimed at accelerating growth.

Identitii reports solid quarterly progress highlighted by a strategic new director appointment, US market expansion, and a successful $1.8 million capital raise, underpinning its path toward profitability.

ASF Group Limited reported a $1.58 million cash balance for the December 2024 quarter, highlighting ongoing investments and a director retirement that could influence its strategic direction.

African Gold Ltd confirms a trading halt as it finalises key exploration results and navigates recent executive changes, signaling pivotal developments for its Didievi Gold Project.

Future Metals NL has identified a promising new mineralised zone at its Eileen Bore Prospect and continues to advance drilling at Target 2, all while implementing strategic cost reductions amid subdued PGM prices.

Kingsgate Consolidated Limited reported a 150% increase in ore mined and a 13.4% rise in gold production for the December 2024 quarter, marking its third consecutive quarter of growth. Despite some challenges with grade control and cost guidance, the company anticipates further production and efficiency gains.

Tryptamine Therapeutics has reported successful Phase 1b results for its IV-infused psilocin candidate TRP-8803 and promising interim data for oral psilocybin TRP-8802 in IBS treatment, while securing $6 million in new funding to accelerate clinical development.